Literature DB >> 18207143

Toxoplasma gondii: enzyme-linked immunosorbent assay using different fragments of recombinant microneme protein 1 (MIC1) for detection of immunoglobulin G antibodies.

Lucyna Holec1, Artur Gasior, Anna Brillowska-Dabrowska, Józef Kur.   

Abstract

Three different fragments of microneme 1 protein termed, r-MIC1ex2, r-MIC1ex34 and r-MIC1 of Toxoplasma gondii, were expressed in Escherichia coli as fusion proteins containing six histidyl residues at N- and C-terminal. After purification by metal affinity chromatography, these recombinant proteins were tested for their usefulness as antigens in an enzyme-linked immunosorbent assay for the detection of immunoglobulin G. Ninety-eight sera from patients with different stages of invasion and 24 sera from seronegative patients were examined. There was no significant difference observed in the antigenicity for human serum samples from patients with acute toxoplasmosis between three recombinant types of MIC1 antigen (96.1% for r-MIC1ex2 antigen and 100% for both r-MIC1ex34 and r-MIC1 proteins). Sera from chronic infections (with low titers of IgG antibody) showed significant lower sensitivity, especially for r-MIC1ex34 and r-MIC1 antigens (75%, 52.7% and 36.1% for r-MIC1ex2, r-MIC1ex34 and r-MIC1, respectively). These results indicate that the strongest antigenic region of the MIC1 is encoding by the second exon of mic1 gene. When r-MIC1ex2 (N-terminal fragment of protein) was combined with MAG1 (matrix antigen) and MIC3 (microneme 3 protein), the sensitivity increased to 88.9%. This result was comparable to an ELISA using a Toxoplasma lysate antigen (TLA) and two combinations of recombinant antigens: M1 (GRA1+GRA7+SAG1) and M2 (P35+SAG2+GRA6) with the sensitivity for serum samples tested 94.4%, 88.9% and 94.4%, respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18207143     DOI: 10.1016/j.exppara.2007.12.002

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  16 in total

1.  MIC1-MAG1-SAG1 chimeric protein, a most effective antigen for detection of human toxoplasmosis.

Authors:  Lucyna Holec-Gasior; Bartlomiej Ferra; Dorota Drapala
Journal:  Clin Vaccine Immunol       Date:  2012-10-03

2.  Evaluation of a recombinant multiepitope peptide for serodiagnosis of Toxoplasma gondii infection.

Authors:  Jianfang Dai; Min Jiang; Yanyun Wang; Lili Qu; Rujun Gong; Jin Si
Journal:  Clin Vaccine Immunol       Date:  2012-01-04

3.  A new MIC1-MAG1 recombinant chimeric antigen can be used instead of the Toxoplasma gondii lysate antigen in serodiagnosis of human toxoplasmosis.

Authors:  Lucyna Holec-Gąsior; Bartłomiej Ferra; Dorota Drapała; Dariusz Lautenbach; Józef Kur
Journal:  Clin Vaccine Immunol       Date:  2011-11-23

Review 4.  Advances in serological, imaging techniques and molecular diagnosis of Toxoplasma gondii infection.

Authors:  Ali Rostami; Panagiotis Karanis; Shirzad Fallahi
Journal:  Infection       Date:  2018-01-12       Impact factor: 3.553

Review 5.  Toxoplasma gondii recombinant antigens as tools for serodiagnosis of human toxoplasmosis: current status of studies.

Authors:  Lucyna Holec-Gasior
Journal:  Clin Vaccine Immunol       Date:  2013-06-19

6.  A new Toxoplasma gondii chimeric antigen containing fragments of SAG2, GRA1, and ROP1 proteins-impact of immunodominant sequences size on its diagnostic usefulness.

Authors:  Bartłomiej Ferra; Lucyna Holec-Gąsior; Józef Kur
Journal:  Parasitol Res       Date:  2015-06-09       Impact factor: 2.289

7.  Recombinant dense granular protein (GRA5) for detection of human toxoplasmosis by Western blot.

Authors:  Xiao Teng Ching; Yee Ling Lau; Mun Yik Fong; Veeranoot Nissapatorn; Hemah Andiappan
Journal:  Biomed Res Int       Date:  2014-05-29       Impact factor: 3.411

8.  Diagnostic value of a Rec-ELISA using Toxoplasma gondii recombinant SporoSAG, BAG1, and GRA1 proteins in murine models infected orally with tissue cysts and oocysts.

Authors:  Mert Döşkaya; Ayşe Caner; Hüseyin Can; Sultan Gülçe İz; Yaprak Gedik; Aysu Değirmenci Döşkaya; Mina Kalantari-Dehaghi; Yüksel Gürüz
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

9.  Cloning, expression and immunoreactivity of recombinant Toxoplasma gondii GRA5 protein.

Authors:  Zahra Arab-Mazar; Shirzad Fallahi; Ameneh Koochaki; Hadi Mirahmadi; Seyyed Javad Seyyed Tabaei
Journal:  Iran J Microbiol       Date:  2016-10

10.  Borrelia burgdorferi BmpA-BBK32 and BmpA-BBA64: New Recombinant Chimeric Proteins with Potential Diagnostic Value.

Authors:  Weronika Grąźlewska; Bartłomiej Ferra; Monika Rudzińska; Lucyna Holec-Gąsior
Journal:  Pathogens       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.